GSK2256294
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSK2256294, covering 2017-05-09 to 2017-05-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese Smokers [Phase 1]